17 Quotes by Mark Landy

While Johnson & Johnson has the clear technology lead, the risk they run is in setting the price. If the price is favorable, doctors will reward them when new products come to market.

If they do negotiate a lower price, they may open themselves up to litigation by essentially conceding that there has been a problem under management's watch.

If the deals went to shareholders today, we believe Boston Scientific would prevail.

I would venture that we are now outside of gentlemanly territory,

I think a lot of folks had not expected them to be back this quickly.

We are operating in a large vacuum. It's exceedingly difficult to speculate.

The deal will proceed if J&J will get the price it wants. I am not sure Guidant will give them that price.

The fact that they found something else is not a concern. It's almost to be expected. When a policeman pulls you over for speeding and decides to look around your car, there's a good likelihood that if he wants to, he can find something to give you a citation for.

When you have a look at the potential liability they have in infringement cases, you basically could save multiple billions of dollars.